Comparison of psychopathological symptoms in HIV-infected schizophrenic patients with schizophrenic patients without HIV
Suggested citation:
Polyanskiy DA, Kalinin VV. [Comparison of psychopathological symptoms in HIV-infected schizophrenic patients with schizophrenic patients without HIV]. Rossiiskii psikhiatricheskii zhurnal [Russian Journal of Psychiatry]. 2016;(5):68-74. Russian
The aim of the present research was to study separate descriptions of psychopathological symptoms in HIV-infected schizophrenic patients and those without HIV, to search significant differences between groups of positive, negative and general symptomatology. Forty HIV-infected patients with verified diagnosis of schizophrenia were included in the study. Among studied patients there were 23 females (58%) and 17 males (42%). Forty patients with schizophrenia without HIV constituted the control group (23 females, 48% and 21 males (52%)). The psychopathological state of all patients was assessed by means of the special rating scale (PANSS). Immunity was assessed by means of flow cytometry. The main results: there are antagonistic relations between HIV-infection and schizophrenia, leading to the diminution in severity of positive, negative and general psychopathological symptoms in HIV-infected schizophrenic patients, as compared to schizophrenic patients without HIV.
1. VICh-infektsiya i SPID. Natsional'noe rukovodstvo, kratkoe izdanie. Pod red. akad. RAN V.V. Pokrovskogo. M.: OOO Izd. gruppa «GEOTAR-Media»; 2014 g. 518 s. (in Russian) 2. Pokrovskiy V.V. Epidemiologiya i profilaktika VICh-infektsii i SPID. M.: Izdatel'stvo Meditsina;1996. 436 s. (in Russian) 3. Lyketsos C.G., Hanson A.L, Fishman M., Mchugh P.R., Treisman G.J. Screening for Psychiatric Morbidity in a Medical Outpatient Clinic for HIV Infection: The Need for a Psychiatric Presence. The International Journal of Psychiatry in Medicine.1994; 24(2):103-13. 4. Adler M.W. ABC of AIDS. Development of the epidemic. British Medical Journal. 1987; 294 (6579): 1083-5. 5. Shader R. I., Kennedy J. S. Biological treatments. In Comprehensive textbook of psychiatry, 4th edition, edited by Harold I. Kaplan and Benjamin J. Sadock, Williams & Wilkins, Baltimore/London, 1985:2037-49. 6. Sidtis J.J., Price R.W. Early HIV-1 infection and the AIDS dementia complex. Neurology. 1990; 40(2):323. 7. Dilley M.D., Fleminger S. Intracranial Infections. In: David A.S., Fleminger S., Kopelman M.D., Lovestone S., Mellers J.D.S. Lishman’s organic psychiatry: a textbook of neuropsychiatry. 4th Edition. Willey-Blackwell. A John Willey & Sons Ltd, Chichester, West Sussex, UK. 2009; 2(7):414-8. 8. Fernandez F. Neuropsychiatric aspects of human immunodeficiency virus (HIV) infection. Current Psychiatry Reports. 2002; 4(3):228-31. 9. Foster R., Everall I. HIV and AIDS. Chapter published in Lloyd G., Elspeth Guthrie E. Handbook of Liaison Psychiatry. Cambridge University Press. 2007:474-505. 10. King M.B. AIDS, HIV and Mental Health. Cambridge University Press, Cambridge. Journal Article in Psychological Medicine. 1994; 24(2):533. 11. Treisman G.J., Angelino A.F., Hutton H.E. Psychiatric Issues in the Management of Patients With HIV Infection. Journal of the American Medical Association. 2001; 286(22):2857. 12. De Ronchi D., Faranca I., Forti P. Development of Acute Psychotic Disorders and HIV-1 Infection. The International Journal of Psychiatry in Medicine. 2000; 30(2):173-83. 13. Becker J.T., Lopez O.L., Dew M.A., Aizenstein H.J. Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS. 2004; 18(suppl.1):11-8. 14. Sewell D.D., Jeste D.V., Atkinson J.H. et al. HIV-associated psychosis: a study of 20 cases. San Diego HIV Neurobehavioral Research Center Group. American Journal of Psychiatry. 1994; 151(2):237-42. 15. Sewell D.D. Schizophrenia and HIV. Schizophrenia Bulletin. 1996; 22(3):465-73. 16. Querques J., Freudenreich O. Psychiatric aspects of HIV infection and AIDS. In Massachusetts General Hospital. Comprehensive Clinical Psychiatry. Stern T.A., Fava M., Wilens T.E., Rosenbaum J.F. Second Edition. Elsevier. 2016; 57:631. 17. Müller N., Riedel M., Ackenheil M., Schwarz M.J. Immune Function in Schizophrenia: The Role of Disease and Antipsychotic Medication. Advances in Biological Psychiatry. 2001:75-86. 18. Pence B.W., Miller W.C., Whetten K., Eron J.J., Gaynes B.N. Prevalence of DSM-IV-Defined Mood, Anxiety, and Substance Use Disorders in an HIV Clinic in the Southeastern United States. Journal of Acquired Immune Deficiency Syndromes. 2006; 42(3):298-306. 19. Polyanskiy D.A., Kalinin V.V., Mazus A.I., Ol'shanskiy A.Ya. Immunologicheskie i kliniko-psikhopatologicheskie sootnosheniya u VICh-infitsirovannykh, bol'nykh shizofreniey. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. M., № 11. 2013 g., s. 75-8. (in Russian) 20. Polyanskiy D.A., Kalinin V.V., Ol'shanskiy A.Ya., Naryshkin A.V., Kholodov E.Yu. Prognoz sopryazhennosti izmeneniy immunologicheskogo statusa i psikhopatologicheskikh dannykh u VICh-infitsirovannykh bol'nykh shizofreniey. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. M., Tom 115, № 5. 2015 g., 76-81. (in Russian)
DOI: http://dx.doi.org/10.24411/1560-957X-2016-1%25x
Article Metrics
Metrics powered by PLOS ALM